CONTENT ANALYSIS OF THE RANGE OF ANTIALLERGIC DRUGS IN THE REPUBLIC OF UZBEKISTAN FOR 2021-2025

177 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz CONTENT ANALYSIS OF THE RANGE OF ANTIALLERGIC DRUGS IN THE REPUBLIC OF UZBEKISTAN FOR 2021-2025 Akramov U.Dj. Abdullayeva X.K. Tashkent Pharmaceutical Institute, Tashkent city, Republic of Uzbekistan e-mail: [email protected] https://doi.org/10.5281/zenodo.17332503 Relevance: currently, the prevalence of allergic diseases is constantly increasing. Allergic diseases and their complications lead to a decrease in the quality of life and an increase in the need for anti-allergic drugs. In this regard, there is a need to study the pharmaceutical market of antiallergic drugs, which will allow us to determine how modern the range of this group of drugs is in the Republic of Uzbekistan. Purpose of the study: the purpose of our work was to analyze anti-allergic drugs in the pharmaceutical market of Uzbekistan for 2021-2025. Materials and methods: the materials of this study were the State Registers of drugs and medical equipment registered in the Republic of Uzbekistan for 2021-2025 (No. 25-29), which were subjected to content analysis. Results: in Uzbekistan in 2021, 210 trade names of anti-allergic drugs were registered, among which 30.95% of domestic, 51.90% of imported production and 17.14% of production of CIS countries. In 2022, 206 trade names of anti-allergic drugs were registered, among which 29.12% of domestic, 53.88% of imported production and 16.99% of production of CIS countries. In 2023, 201 trade names of anti-allergic drugs were registered, including 31.80% of domestic, 52.30% of imported production and 15.90% of production of CIS countries. In 2024, 213 trade names of anti-allergic drugs were registered, including 33.90% of domestic, 48.80% of imported production and 17.20% of production of CIS countries. According to the results of the analysis, it was found that the range of antiallergic drugs as a whole has increased. In 2024, 219 trade names of anti-allergic drugs were registered, including 35.19% of domestic, 51.10% of imported production and 13.71% of production of CIS countries. According to the results of the analysis, it was found that the range of antiallergic drugs as a whole has increased: Years The general range of anti-allergic drugs Anti-allergic drugs of manufacturers of Uzbekistan CIS countries Foreign countries 2021 210 65 36 109 2022 206 60 35 111 2023 201 62 36 103 2024 213 72 35 96 2025 219 77 30 112 A comparative analysis of the range of anti-allergic drugs by producing countries was also carried out. The data obtained indicate that anti-allergic drugs are presented in a wide range. Based on the results of the analysis, it was found that the largest number of antiallergic drugs falls on the share of Uzbekistan (41.91%), then India (20.66%), Turkey (8.10%), Russia (6.40%) and Ukraine (5.65%). 178 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz Conclusions: during the research period, there was a tendency to increase the number and share of trade names of anti-allergic drugs of foreign and domestic production. The increase in the number of anti-allergic drugs of domestic production in the pharmaceutical market of Uzbekistan is of great social and economic importance.